Offer - Urjas Oil for just ₹ 1 X
Spectrazid 1 GM Injection is a prescription medicine that is available as a Injection. It is typically used for the treatment of Skin Infections, Pneumonia. The alternative uses of Spectrazid 1 GM Injection have also been explained below.
The right dosage of Spectrazid 1 GM Injection depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Spectrazid 1 GM Injection have been listed ahead. Normally, these side effects of Spectrazid 1 GM Injection are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Spectrazid 1 GM Injection is Safe for pregnant women and Safe for women who are breastfeeding. It is important to know if Spectrazid 1 GM Injection has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Spectrazid 1 GM Injection related warnings section.
Spectrazid 1 GM Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Spectrazid 1 GM Injection in conditions like Kidney Disease. Some other conditions that can be affected by Spectrazid 1 GM Injection are listed in the contraindications section below.
Besides this, Spectrazid 1 GM Injection may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Spectrazid 1 GM Injection is considered not safe while driving, and is not addictive.
Spectrazid 1 GM Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
Is the use of Spectrazid 1 GM Injection safe for pregnant women?
There are no side effects of Spectrazid in pregnant women.
Is the use of Spectrazid 1 GM Injection safe during breastfeeding?
Spectrazid is completely safe for breastfeeding women.
What is the effect of Spectrazid 1 GM Injection on the Kidneys?
Spectrazid rarely harms the kidneys.
What is the effect of Spectrazid 1 GM Injection on the Liver?
Spectrazid does not damage the liver.
What is the effect of Spectrazid 1 GM Injection on the Heart?
There are no any side effects of Spectrazid for the heart.
If you are suffering from any of the following diseases, you should not take Spectrazid 1 GM Injection unless your doctor advises you to do so -
Is this Spectrazid 1 GM Injection habit forming or addictive?
No, you will not get addicted to Spectrazid 1 GM Injection.
Is it safe to drive or operate heavy machinery when consuming?
After taking Spectrazid 1 GM Injection you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Spectrazid 1 GM Injection only as per medical advice.
Is it able to treat mental disorders?
No, the use of Spectrazid 1 GM Injection in mental disorders is not effective.
Interaction between Food and Spectrazid 1 GM Injection
It is safe to take Spectrazid 1 GM Injection with food.
Interaction between Alcohol and Spectrazid 1 GM Injection
It is difficult to say anything about the effect of Spectrazid 1 GM Injection and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; FORTAZ® (ceftazidime)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-312